Synonyms:ondansetron, 99614-02-5, Zofran, Zudan, 9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-2,3-dihydro-1H-carbazol-4(9H)-one, Zofran ODT, Zuplenz, 116002-70-1, 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one, GR 38032, 4AF302ESOS, 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one, CHEBI:7773, DTXSID8023393, 99614-01-4, A04AA01, EUR-1025, 1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one, NSC-757870, NCGC00179341-02, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one, 9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one, 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one, GR 38032 (hydrochloride);SN 307 (hydrochloride), DTXCID803393, ondansetron (Zofran), GR 38032X, CAS-99614-02-5, Ondansetron Injection, Zofran ODT (TN), GR-C507/75, DESMETHYLONDANSETRON, UNII-4AF302ESOS, BRN 3622981, Ondansetron (JAN/USP/INN), Ondansetron [USP:INN:BAN], SR-01000763250, CHEMBL46, ONDANSETRON [MI], 9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride dihydrate, Prestwick0_001058, Prestwick1_001058, Prestwick2_001058, Prestwick3_001058, ONDANSETRON [INN], ONDANSETRON [JAN], Odansetron [common misspelling of ondansetron], ONDANSETRON [VANDF], SCHEMBL4542, TimTec1_001750, (RS)-1,2,3,9-Tetrahydro-9-methyl-3-(2-methylimidazol-1-ylmethyl)carbazol-4-one, ONDANSETRON [MART.], Oprea1_435466, Oprea1_852372, BSPBio_001016, CBDivE_008994, ONDANSETRON [USP-RS], ONDANSETRON [WHO-DD], MLS006011928, SPBio_002938, BPBio1_001118, GTPL2290, BDBM85330, HSDB 8304, HY-B0002B, ONDANSETRON [ORANGE BOOK], (3S)-9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one, HMS2090H16, HMS3259H08, HMS3371E18, ONDANSETRON [USP MONOGRAPH], ACT02589, BCP28911, Tox21_113048, CAS_68647, MFCD00833882, NSC_68647, NSC791005, s1996, STK370548, AKOS000599484, AKOS016340526, Tox21_113048_1, BCP9001025, DB00904, GR38032, KS-5227, NC00706, NSC 757870, NSC-791005, 1,2,3,4-Tetrahydro-9-methyl-3-(2-methyl-1H-imidazol-1-ylmethyl)carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H- carbazol-4-one, 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-, NCGC00179341-04, NCGC00179341-07, NCGC00179341-12, AC-28927, GR-38032, NCI60_022780, SMR001307702, GR-38032F/GR-38032, Ondansetron(base and/or unspecified salts), GR 38032F;GR-C507/75, AB00373674, FT-0631004, C07325, D00456, EN300-117273, AB00373674-15, AB00373674-17, AB00373674_18, AB00373674_19, L000456, Q410011, SR-01000763250-4, BRD-A19736161-001-01-8, BRD-A19736161-003-03-0, Z1501485364, (+/-)-2,3-DIHYDRO-9-METHYL-3-((2-METHYLIMIDAZOL-1-YL)METHYL)CARBAZOL-4(1H)-ONE, 1,2,3,9,-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one, 1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1yl)methyl]-4H-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazole-1 -yl)methyl]-4H-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazole-1-yl)methyl]-4H-carbazol-4-one, 4H-Carbazol-4-one,?1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-, 9-Methyl-3- (2-methyl-imidazol-1ylmethyl)-1,2,3,9-tetrahydro-carbazol-4-one, 9-Methyl-3-[(2-methyl-1H-imidazolyl)methyl]-1,2,3,9-tetrahydro-4H-carbazole-4-one, 4H-CARBAZOL-4-ONE, 1,2,3,9-TETRAHYDRO-9-METHYL-3-((2-METHYL-1H-IMIDAZOL-1-YL)METHYL)- (+/-)-
Pubchem:PUBCHEM:4595
Id:b3a4065f-422e-5c95-96a5-0a3121e9db2b
Description:nan
